We are live on ! Find out more
Creative Planning

Creative Planning Portfolio holdings

AUM $147B
1-Year Est. Return 18.73%
This Fund
S&P 500
This Quarter Est. Return
+2.62%
1 Year Est. Return
+18.73%
3 Year Est. Return
+48.71%
5 Year Est. Return
+44.71%
10 Year Est. Return
+145.34%
AUM
$29.7B
AUM Growth
+$1.97B
Cap. Flow
+$1.27B
Cap. Flow %
4.28%
Top 10 Hldgs %
54.74%
Holding
2,185
New
207
Increased
867
Reduced
691
Closed
168

Sector Composition

Rank Sector Weight
1 Financials 4.86%
2 Technology 4.06%
3 Healthcare 2.07%
4 Industrials 1.87%
5 Consumer Discretionary 1.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ARCT icon
1001
Arcturus Therapeutics
ARCT
$157M
$576K ﹤0.01%
60,971
COO icon
1002
Cooper Companies
COO
$13.7B
$576K ﹤0.01%
6,836
-536
-7% -$40.3K
DHS icon
1003
WisdomTree US High Dividend Fund
DHS
$1.56B
$576K ﹤0.01%
7,919
+120
+2% +$8.68K
FFIN icon
1004
First Financial Bankshares
FFIN
$4.97B
$576K ﹤0.01%
18,701
-29,319
-61% -$882K
RSPT icon
1005
Invesco S&P 500 Equal Weight Technology ETF
RSPT
$5.38B
$576K ﹤0.01%
32,450
+890
+3% +$15.4K
ZEN
1006
DELISTED
ZENDESK INC
ZEN
$575K ﹤0.01%
6,463
+283
+5% +$24.3K
OMC icon
1007
Omnicom Group
OMC
$22.7B
$573K ﹤0.01%
6,992
+1,314
+23% +$104K
BRK.B icon
1008
CALL
Berkshire Hathaway Class B
BRK.B
$1.07T
$571K ﹤0.01%
160,000
+10,000
+7% +$2.07M
EGBN icon
1009
Eagle Bancorp
EGBN
$867M
$570K ﹤0.01%
10,527
-44
-0.4% -$2.4K
SUPN icon
1010
Supernus Pharmaceuticals
SUPN
$2.68B
$570K ﹤0.01%
17,228
+3,802
+28% +$130K
NDLS icon
1011
Noodles & Co
NDLS
$90.5M
$569K ﹤0.01%
9,019
TTWO icon
1012
Take-Two Interactive
TTWO
$43B
$569K ﹤0.01%
5,011
-380
-7% -$39.1K
BKLN icon
1013
Invesco Senior Loan ETF
BKLN
$7.1B
$566K ﹤0.01%
24,998
-1,001
-4% -$22.8K
PCG icon
1014
PG&E
PCG
$47.8B
$565K ﹤0.01%
24,659
+4,222
+21% +$84.8K
JPS
1015
DELISTED
Nuveen Preferred & Income Securities Fund
JPS
$565K ﹤0.01%
59,426
+11,126
+23% +$103K
VEDL
1016
DELISTED
Vedanta Limited American Depostary Shares (Each representing four equity shares)
VEDL
$564K ﹤0.01%
55,439
+6,035
+12% +$59.4K
AGCO icon
1017
AGCO
AGCO
$8.78B
$560K ﹤0.01%
7,222
ETV
1018
Eaton Vance Tax-Managed Buy-Write Opportunities Fund
ETV
$1.71B
$557K ﹤0.01%
37,053
-9,050
-20% -$134K
PPLI
1019
People Inc
PPLI
$3.1B
$556K ﹤0.01%
14,302
+1,466
+11% +$58.5K
EEMV icon
1020
iShares MSCI Emerging Markets Min Vol Factor ETF
EEMV
$3.45B
$555K ﹤0.01%
9,431
-1,080
-10% -$63.1K
RBCAA icon
1021
Republic Bancorp
RBCAA
$1.84B
$555K ﹤0.01%
11,150
ARLP icon
1022
Alliance Resource Partners
ARLP
$3.18B
$553K ﹤0.01%
32,589
-2,215
-6% -$40.2K
MOH icon
1023
Molina Healthcare
MOH
$10.3B
$551K ﹤0.01%
3,847
-327
-8% -$44.8K
UPLD icon
1024
Upland Software
UPLD
$12M
$551K ﹤0.01%
1,210
+110
+10% +$50.4K
ALSN icon
1025
Allison Transmission
ALSN
$10.1B
$550K ﹤0.01%
11,877
-24
-0.2% -$1.09K

Similar funds

Creative Planning's Q2 2019 Portfolio in Review

As of Q2 2019, Creative Planning held 2,185 positions worth $29.7B, up 7.1% from $27.8B the previous quarter. Its ten largest holdings account for 55% of the portfolio.

Creative Planning deployed $1.27B of net new capital in Q2 2019, opening 207 new positions and adding to 867 existing holdings. Its largest new stake was Dow Inc: 108,999 shares worth $5.38M.

By sector, the portfolio is most concentrated in Financials at 4.9% of assets, up from 4.7% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Vanguard Mid-Cap ETF, an estimated $115M trimmed.

  • Creative Planning's largest Q2 2019 buy was Dow Inc: 108,999 shares worth $5.38M.
  • Creative Planning added most to iShares Core US Aggregate Bond ETF in Q2 2019, an estimated $297M increase.
  • Creative Planning's biggest Q2 2019 reduction was Vanguard Mid-Cap ETF, cutting an estimated $115M.
  • Creative Planning fully exited Intercept Pharmaceuticals, Inc. in Q2 2019, selling an estimated $3.71M.
  • Creative Planning's ten largest holdings make up 55% of its $29.7B portfolio in Q2 2019.
  • Creative Planning opened 207 new positions and closed 168 in Q2 2019.
  • Creative Planning's portfolio value rose 7.1% quarter-over-quarter to $29.7B.

Based on Creative Planning's 13F filing for Q2 2019, filed 26 Jul 2019.